Our findings reveal that MALT1, AR, p53, NDRG1, and MASPIN are CAPE-modulated genes in prostate carcinoma cells and responsible for CAPE-mediated cell growth inhibition. The gene discussed is NDRG1; the disease is prostate carcinoma.